Skip to Content

News: Host-Tumor Interactions Research Program

Study reveals new strategy for reducing tumor growth, metastasis

Thursday, December 17th, 2020

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.

V Scholar Award to support Byndloss’ cancer research

Wednesday, November 18th, 2020

Mariana Byndloss, DVM, PhD, assistant professor of Pathology, Microbiology and Immunology, has received a V Scholar Award from the V Foundation for Cancer Research.

New therapeutic target for lung cancer

Thursday, November 12th, 2020

Continuous activation of cell surface receptors increases signaling that can promote oncogenic transformation. One receptor, EphA2, has been identified as a driver of lung cancer, but its interacting partners are not well characterized.

Richmond receives legacy award from Society for Leukocyte Biology

Thursday, December 12th, 2019

Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.

Project seeks new way to assess immunotherapy effectiveness

Thursday, November 7th, 2019

GE Healthcare has awarded researchers $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.

Rathmell lands award from Lupus Research Alliance

Thursday, October 31st, 2019

Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

Pietenpol, Wilson land Komen cancer research support

Thursday, October 24th, 2019

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Potential second-line melanoma treatment identified

Friday, August 30th, 2019

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

New window on fibrosis

Friday, August 9th, 2019

A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.

Center for Immunobiology grows, bolsters program

Friday, July 19th, 2019

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Next Page »